References
- Managing Sepsis and Septic Shock: Current Guidelines and Definitions. AJN 2018; 118(2):34-39.
- Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315(8): 801-10.
- Georgescu AM, Grigorescu BL, Chirteș IR, Vitin A, Fodor RS. The Relevance of Coding Gene Polymorphisms of Cytokines and Cellular Receptors in Sepsis. The Journal of Critical Care Medicine 2017;3(1):5-11.
- Georgescu AM, Banescu C, Badea I et al. IL-6 gene polymorphisms and sepsis in ICU adult romanian patients: a prospective study. Rev Romana Med Lab. 2017; 25(1):75-89.
- Nargis W, Ibrahim MD, Ahamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014 Jul-Sep; 4(3): 195–199.
- Rauniyar K, Kumar Jha S, Jeltsch M. Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Front Bioeng Biotechnol. 2018; 6: 7.
- S. Ramakrishnan, Anand V, Roy S.. Vascular Endothelial growth factor signalling in hypoxia and Inflammation. J Neuroimmune Pharmacol. 2014 Mar; 9(2): 142–160.
- Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 8(6): 464-478.
- Azamfirei L, Gurzu S, Solomon R et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiologica. 2010 August;76(8):609-16.
- Y. Zhang, Lu Y, Ma L et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signalling and protects against endotoxin shock. Immunity. 2014; 40:501–514.
- Schorr C, Zanotti S, Dellinger RP. Severe sepsis and septic shock. Virulence. 2014 Jan 1; 5(1): 190–199.
- Yano K, Liaw PC, Mullington JM et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006 Jun 12; 203(6): 1447–1458.
- Karlsson S, Pettila V, Tenhunen J et al. Vascular Endothelial Growth Factor in Severe Sepsis and Septic Shock. Anesth Analg, 2008;106:1820-1826.
- Tilea I, Popa DS, Xantus TSZ et al. Determination of Apixaban Levels in Human Plasma by a High-Throughput Liquid Chromatographic Tandem Mass Spectrometry Assay. Rev Romana Med Lab. 2015; 23(1):115-126.
- Namba S, Yamaoka-Tojo M, Kakizaki R et al. Efects on bone metabolism markers and arterial stifness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels. 2017; 32(8):977-982.
- Varga A, Farczadi L, Vlase L et al. Liquid Chromatography Tandem Mass Spectrometry Simultaneous Determination of Amlodipine and Telmisartan in Human Plasma for Therapeutic Drug Monitoring. Rev Chim. 2015; 66(10):1675-1679.
- Di Filippo L, Dos Santos KC, Hanck-Silva G et al. A Critical Review of Biological Properties, Delivery Systems and Analytical/ Bioanalytical Methods for Determination of Bevacizumab. Crit Rev Anal Them. 2020; 10.1080/10408347.2020.1743641.
- EL-Akabawy H, Hamela MA, Gaber A, Abozekry A. Prognostic value of vascular endothelial growth factor in sepsis syndrome. The Egyptian Journal of Critical Care Medicine 2016; 4:119126.
- Shapiro IN, Yano K, Okada H et al. A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock. 2008 Apr; 29(4): 452–457.
- Raith EP, Udy AA, Bailey M et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 2017; 317(3): 290-300.
- Zhang RY, Zhang H, Huang J, Qu HP, Tang YQ. Angiogenic factors in sepsis: are we ready for the new therapeutic era? Crit Care. 2014; 18(1): 403.